MedTrace Logo

Fluid Balance During Surgery for Ovarian Cancer

NCT03006939 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2016-12-30

No results posted yet for this study

Summary

Extensive tumour debulking challenges both surgeon and anaesthesiologist but promotes survival in late-stage ovarian cancer patients. Little is known about the intraoperative fluid balance and its impact on morbidity and mortality.

Conditions

  • Ovarian Neoplasm
  • Fluid Therapy

Interventions

PROCEDURE

Cytoreductive surgery

Cytoreductive surgery in terms of tumor debulking is performed in order to promote survival

Sponsors & Collaborators

  • University Hospital, Bonn

    lead OTHER

Principal Investigators

  • Martin Soehle, MD, PhD · University Clinic Bonn

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2019-12-31
Completion
2022-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03006939 on ClinicalTrials.gov